Publication:
Semen analysis results are negatively affected in patients \rwith vitiligo: A cross-sectional study from Turkey

Simple item page
dc.contributor.authorGüngör, Kağan
dc.contributor.authorDokuzeylül Güngör, Nur
dc.contributor.authorYurci, Arzu
dc.contributor.authorÇil, Kaan
dc.contributor.authorKavrut, Müstecep
dc.contributor.institutionİstanbul Medeniyet Üniversitesi
dc.contributor.institutionBahçeşehir Üniversitesi
dc.contributor.institutionT.C. Sağlık Bakanlığı
dc.contributor.institutionYabancı Kurumlar
dc.contributor.institutionTanımlanmamış Kurum
dc.date.accessioned2025-09-20T19:55:59Z
dc.date.issued2022
dc.date.submitted08.07.2022
dc.description.abstractObjective: Male fertility can be affected by a variety of organ diseases, commonly \rincluding the testis, in the form of cryptorchidism and hypogonadism. The evidence \rrelated to the fact that male infertility depends on skin disease is still not adequate. \rThe aim of the study was to evaluate the clinical features and semen analysis results \rof vitiligo patients and control cases.\rMaterial and Methods: This cross-sectional study was conducted between January \r2015 and January 2021 by retrospectively evaluating patients who underwent sperm \ranalysis at İstanbul Medeniyet University Göztepe Training and Research Hospital. \rPatients with vitiligo (n=76) were included in the study as the vitiligo group. The control group was selected from age- and body mass index-matched patients who underwent semen analysis (n=71).\rResults: The mean age was 30.29±4.18 years, the mean age at onset of vitiligo was \r23.66±3.96 years, and the mean disease duration was 6.36±2.80 years in the vitiligo \rgroup. The free T4 (FT4) levels were significantly lower in the vitiligo group than in \rthe control group (p<0.001). When we evaluated semen analysis results, we found \rsperm concentration (p<0.001), A + B motility (p<0.01), and morphology (p<0.001) \rsignificantly better in the controls than in the patients with vitiligo.\rConclusion: We found that the FT4 level was lower, and semen analysis results were \rnegatively affected in patients with vitiligo. The clinical management of vitiligo should \ralso include its effects on the semen and the male reproductive system.
dc.identifier.doi10.14744/zkmj.2022.48802
dc.identifier.endpage74
dc.identifier.issn2757-8062
dc.identifier.issue2
dc.identifier.startpage68
dc.identifier.urihttps://hdl.handle.net/20.500.14719/4616
dc.identifier.volume53
dc.language.isoen
dc.relation.journalZeynep Kamil medical journal (Online)
dc.subjectAndroloji
dc.titleSemen analysis results are negatively affected in patients \rwith vitiligo: A cross-sectional study from Turkey
dc.typeResearch Article
dcterms.references1. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE, Vitiligo Working Group. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol 2017,77:1–13.,2. Zhang Y, Cai Y, Shi M, Jiang S, Cui S, Wu Y, et al. The prevalence of Vitiligo: A meta-analysis. PLoS One 2016,11:e0163806.,3. Halder RM, Chappell JL. Vitiligo update. Semin Cutan Med Surg 2009,28:86–92.,4. Bergqvist C, Ezzedine K. Vitiligo: A review. Dermatology 2020,236:571– 92.,5. Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol 2015,13:37.,6. Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci 2015,8:191–6.,7. Abdel-Naser MB, Zouboulis CC. Male fertility and skin diseases. Rev Endocr Metab Disord 2016,17:353–65.,8. Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, et al. Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012,25:E1–13.,9. Yuan J, Sun C, Jiang S, Lu Y, Zhang Y, Gao XH, et al. The prevalence of thyroid disorders in patients with vitiligo: A systematic review and meta\u0002analysis. Front Endocrinol (Lausanne) 2019,9:803.,10. Mubki T, Alissa A, Mulekar S, Albargawi S, Youssef M, Aljasser M. Asso\u0002ciation of vitiligo with anemia, vitamin B12 deficiency, diabetes mellitus, and thyroid dysfunction in Saudi Arab patients: A case control study. J Dermatol Dermatol Surg 2017,21:72–6.,11. Wajner SM, Wagner MS, Maia AL. Clinical implications of altered thy\u0002roid status in male testicular function. Arq Bras Endocrinol Metabol 2009,53:976–82.,12. La Vignera S, Vita R. Thyroid dysfunction and semen quality. Int J Im\u0002munopathol Pharmacol 2018,32:2058738418775241.,13. Bisht S, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infer\u0002tility. Nature Reviews Urology 2017,14:470–85.,14. Alahmar AT. Role of oxidative stress in male infertility: An updated re\u0002view. J Hum Reprod Sci 2019,12:4–18.,15. Umaoka A, Takeuchi H, Mizutani K, Seo N, Matsushima Y, Habe K, et al. Skin inflammation and testicular function: Dermatitis causes male infer\u0002tility via skin-derived cytokines. Biomedicines 2020,8:293.,16. Azenabor A, Ekun AO, Akinloye O. Impact of inflammation on male re\u0002productive tract. J Reprod Infertil 2015,16:123–9.,17. Frisoli ML, Harris JE. Vitiligo: Mechanistic insights lead to novel treat\u0002ments. J Allergy Clin Immunol 2017,140:654–62.,18. Solak B, Dikicier BS, Cosansu NC, Erdem T. Neutrophil to lymphocyte ratio in patients with vitiligo. Postepy Dermatol Alergol 2017,34:468– 70.,19. Boniface K, Seneschal J, Picardo M, Taïeb A. Vitiligo: Focus on clinical aspects, ımmunopathogenesis, and therapy. Clin Rev Allergy Immunol 2018,54:52–67.,20. van den Wijngaard R, Wankowicz-Kalinska A, Pals S, Weening J, Das P. Autoimmune melanocyte destruction in vitiligo. Lab Invest 2001,81:1061–7.,21. Spritz RA, Andersen GH. Genetics of vitiligo. Dermatol Clin 2017,35:245– 55.,22. Speeckaert R, Dugardin J, Lambert J, Lapeere H, Verhaeghe E, Speeckaert MM, et al. Critical appraisal of the oxidative stress pathway in vitiligo: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2018,32:1089–98.,23. Eisenberg ML, Li S, Behr B, Pera RR, Cullen MR. Relationship between semen production and medical comorbidity. Fertil Steril 2015,103:66– 71.,24. Stratakis CA. Carney complex: A familial lentiginosis predisposing to a variety of tumors. Rev Endocr Metab Disord 2016,17:367–71.,25. Sharma ST, Nieman LK, Feelders RA. Cushing’s syndrome: Epidemi\u0002ology and developments in disease management. Clin Epidemiol 2015,7:281–93.,26. de Kerviler E, Guermazi A, Zagdanski AM, Gluckman E, Frija J. The clinical and radiological features of Fanconi’s anaemia. Clin Radiol 2000,55:340–5.,27. Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, Hiel JA, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 2009,73:430–7.,28. Blyth M, Maloney V, Beal S, Collinson M, Huang S, Crolla J, et al. Pallister-Killian syndrome: A study of 22 British patients. J Med Genet 2015,52:454–64.,29. Bagherani N. The Newest hypothesis about Vitiligo: Most of the sug\u0002gested pathogeneses of vitiligo can be attributed to lack of one factor, Zinc-α2-Glycoprotein. ISRN Dermatol 2012,2012:405268.,30. El-Rifaie AAAS, Gohary YM, Abd-El Aziz GM, Owies FO. Zinc-α2- Glycoprotein (ZAG): A new deficiency in vitiligo patients. Skinmed 2019,17:248–53.,31. Wei X, Liu X, Tan C, Mo L, Wang H, Peng X, et al. Correction to: Expres\u0002sion and function of Zinc-α2-Glycoprotein. Neurosci Bull 2019,35:778.,32. Severo JS, Morais JBS, Beserra JB, Dos Santos LR, de Sousa Melo SR, de Sousa GS, et al. Role of zinc in Zinc-α2-glycoprotein metabolism in obesity: A review of literature. Biol Trace Elem Res 2020,193:81–8.,33. Liu M, Zhu H, Dai Y, Pan H, Li N, Wang L, et al. Zinc-α2-Glycoprotein is associated with obesity in Chinese people and HFD-Induced obese mice. Front Physiol 2018,9:62.,34. Frenette G, Thabet M, Sullivan R. Polyol pathway in human epididymis and semen. J Androl 2006,27:233–9.,35. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F. Zinc alpha 2-glyco\u0002protein: A multidisciplinary protein. Mol Cancer Res 2008,6:892–906.,36. Ding Z, Qu F, Guo W, Ying X, Wu M, Zhang Y. Identification of sperm forward motility-related proteins in human seminal plasma. Mol Reprod Dev 2007,74:1124–31.
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Semen analysis results are negatively affected in patients with vitiligo A cross-sectional study from Turkey.pdf
Size:
280.86 KB
Format:
Adobe Portable Document Format
Download

Collections

TR-Dizin İndeksli Yayınlar Koleksiyonu